tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Caroline Palomeque, 4 are a BUY (80%), 1 are a HOLD (20%).
Analyst Caroline Palomeque, carries an average stock price target met ratio of 75% that have a potential upside of 133.16% achieved within 782 days.
Caroline Palomeque’s has documented 8 price targets and ratings displayed on 2 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on DARE, Dare Bioscience at 13-Aug-2024.
Analyst best performing recommendations are on DARE (DARE BIOSCIENCE).
The best stock recommendation documented was for AVXL (ANAVEX LIFE SCIENCES CORP) at 5/16/2018. The price target of $7 was fulfilled within 904 days with a profit of $4.56 (186.89%) receiving and performance score of 2.07.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$46
$34.89 (314.04%)
$46
3 months 8 days ago
(06-Apr-2025)
6/11 (54.55%)
$37.67 (452.22%)
1278
Buy
$42
$30.89 (278.04%)
$42
3 months 8 days ago
(06-Apr-2025)
4/15 (26.67%)
$33.67 (404.20%)
155
Buy
$28
$19.49 (229.02%)
$35
2 years 5 months 5 days ago
(09-Feb-2023)
0/2 (0%)
$17.59 (168.97%)
Hold
$11
$-0.11 (-0.99%)
$16
2 years 7 months 9 days ago
(05-Dec-2022)
4/7 (57.14%)
$2.62 (31.26%)
134
Buy
$40
$31.49 (370.04%)
$7
3 years 21 days ago
(23-Jun-2022)
1/2 (50%)
$29.55 (282.78%)
904
What Year was the first public recommendation made by Caroline Palomeque?
